Effect of Herbal tablet Pinak on HIV, Hepatitis B and HEPATITIS C corona viruses
Phase 3
- Conditions
- Health Condition 1: B181- Chronic viral hepatitis B withoutdelta-agentHealth Condition 2: B182- Chronic viral hepatitis CHealth Condition 3: B20- Human immunodeficiency virus [HIV]disease
- Registration Number
- CTRI/2021/10/037309
- Lead Sponsor
- Sudesh Shiva Devadiga
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Diagnosed Patients of AIDS
Diagnosed Patients of Hepatitis B
Diagnosed Patients of Hepatitis C
Subjects voluntarily providing written informed consent and willing to give regular follow-up
Exclusion Criteria
Following death prone toxic cases will be excluded
Subjects with life expectancy less than 1 year
Associated serious diseases
Patients in ICU
Patients with ventilator
Patients with renal failure
All pediatrics cases
All pregnant cases
All lactating cases
LFT more than 3 times upper limit of normal
Hypersensitivity to any of the ingredients of study product
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method